Y Lorcy

726 total citations
28 papers, 453 citations indexed

About

Y Lorcy is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Y Lorcy has authored 28 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Y Lorcy's work include Thyroid Disorders and Treatments (10 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Pituitary Gland Disorders and Treatments (5 papers). Y Lorcy is often cited by papers focused on Thyroid Disorders and Treatments (10 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Pituitary Gland Disorders and Treatments (5 papers). Y Lorcy collaborates with scholars based in France, Switzerland and United Kingdom. Y Lorcy's co-authors include H Allannic, R Fauchet, B Genetet, Jacques Orgiazzi, M. Guéguen, Isabelle Guilhem, D Maugendre, J.Y. Herry, Anne-Marie Leguerrier and L. Campion and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and European Journal of Endocrinology.

In The Last Decade

Y Lorcy

25 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y Lorcy France	8	377	107	78	63	43	28	453
Margita Zakarija United States	10	376 1.0×	114 1.1×	38 0.5×	94 1.5×	11 0.3×	13	464
Nathalie Beressi France	8	246 0.7×	43 0.4×	24 0.3×	34 0.5×	40 0.9×	9	330
Anna Bossowska Poland	10	179 0.5×	104 1.0×	71 0.9×	60 1.0×	26 0.6×	24	380
T Kousaka Japan	10	156 0.4×	38 0.4×	40 0.5×	40 0.6×	18 0.4×	33	334
B. M. Goslings Netherlands	12	320 0.8×	79 0.7×	25 0.3×	46 0.7×	44 1.0×	22	411
Paula Scaglia Argentina	10	378 1.0×	236 2.2×	28 0.4×	162 2.6×	18 0.4×	27	471
R Hintz United States	6	259 0.7×	124 1.2×	15 0.2×	237 3.8×	56 1.3×	12	444
Maria Kalina Poland	9	113 0.3×	90 0.8×	15 0.2×	174 2.8×	31 0.7×	26	370
Riccardo Lari Italy	8	334 0.9×	43 0.4×	25 0.3×	81 1.3×	71 1.7×	14	403
Qiao-Yi Chen United States	8	155 0.4×	213 2.0×	42 0.5×	43 0.7×	15 0.3×	14	375

Countries citing papers authored by Y Lorcy

Since Specialization

Citations

This map shows the geographic impact of Y Lorcy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Lorcy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Lorcy more than expected).

Fields of papers citing papers by Y Lorcy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Lorcy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Lorcy. The network helps show where Y Lorcy may publish in the future.

Co-authorship network of co-authors of Y Lorcy

This figure shows the co-authorship network connecting the top 25 collaborators of Y Lorcy. A scholar is included among the top collaborators of Y Lorcy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Lorcy. Y Lorcy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pierre, P., F Despert, François Tranquart, et al.. (2012). Adrenal rest tissue in gonads of patients with classical congenital adrenal hyperplasia: Multicenter study of 45 French male patients. Annales d Endocrinologie. 73(6). 515–522. 17 indexed citations

Doucet, J., J.‐P. Le Floch, B. Bauduceau, et al.. (2010). Évaluation de la tolérance d’un traitement par insuline detemir ou NPH chez des patients diabétiques de type 2 de 70 ans et plus : « l’étude 3L ». La Revue de Médecine Interne. 31. S140–S140. 1 indexed citations

Lorcy, Y, et al.. (2008). Les nouveaux immunomodulateurs dans le traitement de l’ophtalmopathie basedowienne. Annales d Endocrinologie. 69. S29–S32.

Lorcy, Y, et al.. (2008). Les analogues des hormones thyroïdiennes : un apport biologique important et de nouvelles possibilités thérapeutiques. Annales d Endocrinologie. 69. S33–S36. 3 indexed citations

Baldé, N.M., et al.. (2007). [Long-term outcome of the adult onset craniopharyngiomas].. PubMed. 68(2-3). 186–90. 4 indexed citations

Lorcy, Y & Marc Klein. (2005). Troubles cardiovasculaires d'origine thyroïdienne. 19(2). 1–6.

Lorcy, Y & Marc Klein. (2005). Troubles cardiovasculaires d'origine thyroïdienne. 2(2). 127–135. 3 indexed citations

Lorcy, Y, et al.. (2002). [Acromegaly due to ectopic GH RH secretion by a bronchial carcinoid tumor: a case report].. PubMed. 63(6 Pt 1). 536–9. 3 indexed citations

Lorcy, Y, et al.. (2000). Time Course of GH and IGF-1 Levels Following Withdrawal of Long-Acting Octreotide in Acromegalic Patients. Pituitary. 3(3). 193–197. 20 indexed citations

10.

Maugendre, D, A Gatel, L. Campion, et al.. (1999). Antithyroid drugs and Graves' disease — prospective randomized assessment of long‐term treatment. Clinical Endocrinology. 50(1). 127–132. 88 indexed citations

11.

Allannic, H, et al.. (1991). [Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy].. PubMed. 20(14). 645–6, 649. 7 indexed citations

12.

Allannic, H, et al.. (1990). Antithyroid Drugs and Graves' Disease: A Prospective Randomized Evaluation of the Efficacy of Treatment Duration. The Journal of Clinical Endocrinology & Metabolism. 70(3). 675–679. 136 indexed citations

13.

Lorcy, Y, et al.. (1985). [Cushing's disease caused by probable pituitary microadenoma associated with an intrasellar arachnoidal diverticulum].. PubMed. 14(5). 284–284. 1 indexed citations

14.

Lorcy, Y, et al.. (1984). [Gastric bypass in the treatment of major obesity. 15 cases].. PubMed. 13(41). 2489–92. 1 indexed citations

15.

Allannic, H, R Fauchet, Y Lorcy, et al.. (1983). Properdin factor B (Bf) and glyoxalase in Graves' disease. European Journal of Endocrinology. 102(1). 57–61. 2 indexed citations

16.

Allannic, H, et al.. (1983). A Prospective Study of the Relationship between Relapse of Hyperthyroid Graves’ Disease after Antithyroid Drugs and HLA Haplotype*. The Journal of Clinical Endocrinology & Metabolism. 57(4). 719–722. 35 indexed citations

17.

Allannic, H, et al.. (1981). [A case of permanent neurological sequelae by lithium intoxication during a thyrotoxicosis (author's transl)].. PubMed. 57(29-32). 1349–52.

18.

Allannic, H, R Fauchet, Y Lorcy, et al.. (1980). HLA and Graves' Disease: An Association with HLADRw3. The Journal of Clinical Endocrinology & Metabolism. 51(4). 863–867. 59 indexed citations

19.

Allannic, H, et al.. (1980). [HLA DRW3 and Graves' disease (author's transl)].. PubMed. 41(1). 70–2. 1 indexed citations

20.

Allannic, H, et al.. (1976). [Proceedings: Hyperthyroidism with pyramidal signs: report of a case (author's transl)].. PubMed. 36(6). 365–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact